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The Corona Virus Disease 2019 (COVID-19) out-
break surprised humanity with its scale and speed. 
Starting in Wuhan, the capital city of Central Chi-
na’s Hubei province, it rapidly spreads to East Asia, 
Iran, Europe and the United States of America [1]. 
So far, only a few countries on earth have not yet 
been affected by the pandemic. Dealing with an 
emerging new disease is particularly challenging 
and requires complex decision making and leader-
ship, of both medical leaders and statesmen. Fac-
tors such as logistical and technological capabilities, 
medical staff training level, operational flexibility 
and leadership, will determine how well healthcare 
organizations (and nations) will cope with the chal-
lenge. In this paper, we present six major leadership 
dilemmas and possible solutions, in an attempt to 
provide tools that will assist in confronting such an 
extreme event:
whAt is thE pricE wE ArE willinG tO 
pAY fOr sAvinG livEs?
containment and mitigation policies:
Countries of the world can be schematically divided 
into two main groups according to their choice 
of how to tackle this outbreak: those who acted 
resolutely to quickly control the epidemic from the 
time of its emergence (Singapore, Taiwan, Japan, 
and South Korea) and those who delayed until the 
scale and the severity of the outbreak were apparent 
before taking the appropriate steps (such as Italy, 
Iran, and Spain). It was soon found that morbid-
ity and mortality rates were significantly lower in 
countries that adopted strict citizen isolation and 
closure policies, as well as, massive population test-
ing [2]. Each country has different cultural, social, 
geopolitical, economic and military characteristics 
that affect its ability to function in health crises. The 
structure of the healthcare system, the form of in-
surance coverage and the regulation of the system 
also have a decisive influence on the ability of that 
country to cope with such crises. When confronted 
with an outbreak, determination, decisiveness and 
speed of actions by the medical leaders will not 
only save lives but also reduce the implications of 
associated effects.
whAt is thE stAtE’s cOmmitmEnt tO its 
citizEns And shOuld it BE mAintAinEd 
At All cOsts?
the diamond princess dilemma:
Six days after an 80-year-old guest disembarked 
from this cruise ship on 1st February 2020, he visited 
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a local Hong Kong hospital, where he later diag-
nosed positive for COVID-19 [ 3]. By the end of Feb-
ruary, more than 600 out of the 3.711 passengers 
and crew were infected with the virus [4]. Among 
the passengers were 3 Israeli passengers who test-
ed positive for COVID-19 and were sent to a local 
hospital in Japan for further treatment. On the 17th 
of February, the Israeli government followed several 
other nations and decided to bring home the other 
10 Israeli passengers from quarantined on the ship. 
On the 20th of February, they were transported back 
to Israel and hospitalized in isolated conditions for 
further examination and treatment. This decision 
was criticized by the media and the public because, 
until then, there were no verified COVID-19 cases in 
Israel. The arrival of these citizens carried the risk of 
bringing the virus into the country. The Israeli gov-
ernment (and the medical committee) decided that 
the state’s moral commitment to care for its’ citi-
zens, overcame the fear and the danger surrounding 
this decision. The bad taste of possible rejection the 
return of these citizens would have remained long 
after the end of the pandemic. 
cOntinuE tO prOvidE EssEntiAl  
And lifE-sAvinG mEdicAl sErvicEs,  
Or rEdirEct All rEsOurcEs tO dEAl 
with thE currEnt crisis?
Sheba Medical Center (SMC) is a leading medical 
center in Israel with cutting edge clinical and tech-
nological capabilities. The Israeli Ministry of Health 
(MoH) elected SMC for the management and treat-
ment of the first corona patients, include the Israe-
li returned Diamond Princess’ passengers. This, in 
turn, required both recruiting the most suitable and 
skilled teams and selecting the most appropriate site 
(and facility) within the hospital for the hospitaliza-
tion and treatment of the COVID-19 positive pa-
tients. At that time, there was uncertainty as to the 
optimal model of treatment. It was clear to us that 
we are committed to continuing to provide essential 
and life-saving medical services in order to prevent 
significant harm to citizens’ health. Thus, we chose 
to set up a separate site for the COVID-19 Patients to 
minimize any impairment of the necessary medical 
function at the main hospital. Several considerations 
were taken into account when selecting the site for 
treatment of these patients: isolation, accessibility, 
the safety of the medical teams and other hospital-
ized patients, minimizing disruption of the regular 
medical activities and lifesaving procedures that are 
performed at the hospital, the distance from pop-
ulation centers while still relying on some of the 
capabilities of the hospital. The quickest and most 
convenient way would have been to assign a hos-
pital ward and tailor it to care for these patients, 
drawing on existing organic staff and facilities. In 
order to minimize the danger of exposing patients 
and staff to the virus and the risk of harming the 
hospital’s essential routine activities, we chose 
a dedicated, separated facility. This allowed us to 
deploy and introduce technologies that are not rou-
tinely used in the hospital such as telemedicine for 
in house medical care, wireless sensors, robots etc. 
Additionally, an institutional multidisciplinary team 
was formed including medical directors and experts’ 
physicians in the fields of disaster medicine, internal 
medicine and infectious diseases, public health spe-
cialists, technology and logistics personnel, psychol-
ogists, spokesperson-public relations and ethics-law 
experts. Simulators were used to train the teams, 
familiarize them with the disease characteristics and 
the new tools. The decision where to place the site 
to treat the COVID-19 patients depends on the va-
riety of factors and should be considered according 
to the local conditions. Medical managers need to 
be involved and lead this important decision that 
affects the functioning and availability of medical 
services and the safety of people are hospitalized 
and medical staff.
tEAm EndurAncE  
— thE GrEAtEst chAllEnGE:
the “big picture” dilemma [5] — how much it 
should be shared with the team?
Fear of the unknown is an integral part of such 
a crisis for both the civilians and the medical teams, 
concerned is not only for their safety but for their 
families and patients. As always in crisis, in order 
to minimalize concerns, maintain motivation and 
morale and avoid dissemination of false rumours, 
transparency and openness are required. Along with 
psychological support, this will promote earning 
the trust from both the employees and the gener-
al public.
Eldad Katorza et al., The outbreak of COVID-19 — medical leadership challenge
3www.journals.viamedica.pl
cOmplEx dEcisiOn mAKinG — EthicAl 
And mOrAl dilEmmAs:
what if we must choose who gets cared for 
(and who does not)?
Under such extreme situations, difficult ethical 
dilemmas may emerge, and clear and uniform policy 
is required, to guide providers confronted with dif-
ficult questions. Preparation of special ethics com-
mittees are required, involving ethics experts and 
senior medical leaders do develop limited resource 
allocation policies such as protective equipment, ex-
pensive drugs and allocation of life-saving technol-
ogies such as respirators. These impossible decisions 
should not be left in the hands of the medical teams 
but should be pre-determined and clearly commu-
nicated to them. Quick decision-making based on 
situational analysis, knowledge and experience is 
expected of the medical leadership in extremely dif-
ficult situations. Being late and hesitant in decision 
making can have devastating results. 
cOllABOrAtiOn As A strAtEGY:
how important are communication and 
collaboration?
One of the features of a modern economy is compe-
tition and differentiation. In situations when a com-
mon threat appears, cooperation in the form of 
sharing knowledge and experience are required, on 
both, national and international level. The expe-
rience gained by countries where the virus struck 
earlier could be lifesaving for countries where no 
mass infection has yet occurred. In crisis situations, 
working alone is simply not an option. Collaboration 
in the form of resource and knowledge sharing and 
transfer of equipment between hospitals and states 
is difficult in times of crisis, with everyone taking 
care of themselves, but this is true leadership and 
should be sought after.
While pandemic events are not often, they result 
in significant morbidity, mortality, disruption of life 
and have a major global economic effect. Medical 
teams and medical directors should be appropriately 
prepared and trained to face such a challenge. This 
could allow for controlling such events in the earliest 
stages possible. Leadership are further challenged 
between the epidemics, as they are charged with 
having to influence policy makers to prioritize read-
iness and create collaborations. 
It is not easy to be a leader, but it is the duty of 
the medical leaders who emerge during a crisis. The 
way in which we handle medical leadership dilem-
mas may be of value for the oncoming challenges. 
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